Literature DB >> 7762392

Olfactory threshold and nasal mucosal changes in experimentally induced common cold.

A Akerlund1, M Bende, C Murphy.   

Abstract

Common cold is a most common disease in man accompanied by an experience of a diminished sense of smell. Controlled studies of the sense of smell are lacking and the cause as well as degree of impairment of smell in common cold has not been satisfactorily evaluated. We have investigated whether impaired olfactory ability accompanies common cold and if the loss is related to nasal blockage and to the amount of nasal discharge. For this purpose we measured the threshold of olfaction in volunteers before and after nasal inoculation with coronavirus 229E. The absolute olfactory threshold was assessed by a modified discrimination step test with dilutions of butanol. Symptoms of common cold were registered using a four-grade scale. Nasal obstruction was measured by nasal peak expiratory flow and by acoustic rhinometry and nasal discharge by weight of pre-weighted handkerchiefs. Individuals with a cold had impaired olfaction and the change in smelling ability correlated to the nasal congestion but not to the nasal discharge in analysis of multiple linear regression.

Entities:  

Mesh:

Year:  1995        PMID: 7762392     DOI: 10.3109/00016489509133353

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  29 in total

1.  Work related impairment of nasal function in Swedish woodwork teachers.

Authors:  M Ahman; M Holmström; I Cynkier; E Söderman
Journal:  Occup Environ Med       Date:  1996-02       Impact factor: 4.402

2.  Management of Smell Dysfunction.

Authors:  Livije Kalogjera; Davor Dzepina
Journal:  Curr Allergy Asthma Rep       Date:  2012-02-02       Impact factor: 4.806

Review 3.  Olfactory and gustatory disorders in COVID-19.

Authors:  Ludger Klimek; Jan Hagemann; Julia Döge; Laura Freudelsperger; Mandy Cuevas; Felix Klimek; Thomas Hummel
Journal:  Allergo J Int       Date:  2022-06-20

Review 4.  Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health.

Authors:  Richard L Doty
Journal:  Trends Mol Med       Date:  2022-06-20       Impact factor: 15.272

Review 5.  Olfaction and anosmia in rhinosinusitis.

Authors:  Pamela Dalton
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

6.  Clinical Manifestations of COVID-19.

Authors:  Mahsa Eskian; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.

Authors:  Harini Sri Rethinavel; Sowbarnika Ravichandran; Risna Kanjirassery Radhakrishnan; Mahesh Kandasamy
Journal:  J Chem Neuroanat       Date:  2021-05-11       Impact factor: 3.052

8.  Re-establishment of olfactory and taste functions.

Authors:  Antje Welge-Lüssen
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

Review 9.  A primer on viral-associated olfactory loss in the era of COVID-19.

Authors:  Zachary M Soler; Zara M Patel; Justin H Turner; Eric H Holbrook
Journal:  Int Forum Allergy Rhinol       Date:  2020-06-01       Impact factor: 5.426

10.  Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients.

Authors:  Christian Calvo-Henriquez; Byron Maldonado-Alvarado; Carlos Chiesa-Estomba; Irene Rivero-Fernández; Marta Sanz-Rodriguez; Ithzel María Villarreal; Miguel Rodriguez-Iglesias; Franklin Mariño-Sánchez; Alejandro Rivero-de-Aguilar; Jerome R Lechien; Gabriel Martínez-Capoccioni; Sven Saussez; Robson Capasso; Petros D Karkos; Valentin Schriever; Carlos Martin-Martin; Isam Alobid; Alfonso Santamaría-Gadea; Claudio Fragola; Miguel Mayo-Yáñez; Hugo Pérez-Freixo; Elisabeth Ninchritz-Becerra; María Soriano-Reixach; Elisabeth Mondragon-Rezola; Maria Del Mar Martínez Ruiz-Coello; Raimundo Andrés Navarro; Alfredo García-Fernández; Álvaro Marchan-López
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-24       Impact factor: 3.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.